Jimmy Lin is a pioneer in developing computational approaches to extract insights from large-scale genomic data. He talks to Future about the challenges of executing on a company mission to marry machine learning and biological data. Freenome is developing blood-based tests for early cancer detection, starting with colon cancer.
Table of contents
What Synthetic Embryos Can and Can’t Do, Now and in the FutureHow to Build a GPT-3 for ScienceAI’s Next Frontier: Brains on DemandThe Glittering Treasure in Your Genome’s JunkQuantifying Disease Risk Using Genomics: the New ParadigmJoin the NewsletterSort: